Table 2. Antiviral treatment characteristics of patients with chronic hepatitis C overall and by hepatitis C virus (HCV) genotype.
†N=687 for those with available laboratory or clinical information at the end of treatment and at 6 months afterwards, ‡N=799 for those with available laboratory or clinical information at 6 months after the end of treatment.